Related Experiment Video
Updated: Nov 10, 2025

Preparation of Naringenin Solution for In Vivo Application
Published on: August 10, 2021
Novel compounds from Premna herbacea Roxb. with antidiabetic potential
Gowtham Manikanth1, Asharani Indira Viswambharan2, Paridhavi Mathad3
1Department of Chemistry, School of Advanced Sciences, VIT, Vellore, Tamil Nadu, India/ Rajiv Gandhi Institute of Pharmacy, Trikaripur, Kasaragod, Kerala, India.
Abstract:
Diabetes mellitus is an epidemic that is growing worldwide at an alarming rate. The need for plant-based drugs to combat this epidemic led to the isolation of three new compounds, namely 1-Benzoyloxy-8-tetradecanoyloxy-geranilane (1), 1-Benzoyloxy-8-(octadec-9ꞌꞌ-enoyl) geranilane (2), and 1-Benzoyloxy-8-octadecanoyloxygeranilane (3), from the roots of Premnaherbacea. Their structures were deciphered by 1H NMR, 13C NMR, and 2D-NMR. In vitro (α-amylase and α-glucosidase inhibitory activity) and in vivo antidiabetic activity (streptozotocin- nicotinamide model) were conducted using various groups for which various biochemical parameters and histopathology studies were done. This study confirmed that 1-Benzoyloxy-8-(octadec-9ꞌꞌ-enoyl) geranilane from roots of Premna herbacea have significant antidiabetic and antioxidant activity, thus indicating a corrective effect on diabetes and its complications.
Related Concept Videos
Oral Hypoglycemic Agents: Glinides
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Oral Hypoglycemic Agents: Sulfonylureas
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Oral Hypoglycemic Agents: Biguanides and Glitazones

